Julie C Fitzgerald Selected Research

Antibodies

1/2023	NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2-related complications.
1/2022	Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
6/2013	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie C Fitzgerald Research Topics

Disease

46	Sepsis (Septicemia) 01/2024 - 01/2014
27	Septic Shock (Toxic Shock Syndrome) 01/2024 - 01/2014
18	Critical Illness (Critically Ill) 02/2024 - 09/2014
15	COVID-19 03/2024 - 01/2020
13	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 12/2016
11	Neoplasms (Cancer) 03/2024 - 12/2016
10	Respiratory Insufficiency (Respiratory Failure) 07/2023 - 04/2016
6	COVID-19 related pediatric multisystem inflammatory disease 01/2023 - 01/2021
6	Cytokine Release Syndrome 10/2021 - 06/2013
5	Kidney Diseases (Kidney Disease) 02/2024 - 12/2016
5	Multiple Organ Failure (MODS) 12/2023 - 09/2017
5	Infections 01/2023 - 12/2014
5	Fever (Fevers) 10/2021 - 02/2017
4	Bacterial Infections (Bacterial Infection) 01/2022 - 06/2017
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 06/2013
4	Acute Lung Injury 01/2021 - 09/2014
3	Shock 06/2023 - 11/2016
3	Inflammation (Inflammations) 01/2021 - 01/2020
3	Heart Arrest (Cardiac Arrest) 01/2021 - 01/2017
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2017 - 12/2011
2	Disease Progression 01/2023 - 05/2022
2	Neurologic Manifestations (Neurological Manifestations) 01/2023 - 12/2022
2	Delirium 01/2022 - 01/2021
2	Leukemia 11/2020 - 01/2018
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 02/2020 - 06/2017
2	Hyperlactatemia 01/2019 - 11/2016
2	Macrophage Activation Syndrome 01/2018 - 01/2016
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018 - 06/2013
2	Hyperferritinemia 02/2017 - 06/2013
2	Pulmonary Hypertension 01/2017 - 03/2015
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Lung Injury 11/2023
1	Coinfection 03/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Ventricular Dysfunction 01/2023
1	Respiratory Syncytial Virus Infections 01/2023
1	Aseptic Meningitis 01/2023
1	Central Nervous System Infections (Central Nervous System Infection) 01/2023
1	Human Influenza (Influenza) 01/2023
1	Obesity 01/2023
1	Tachycardia (Tachyarrhythmias) 10/2022
1	Bacteremia 01/2022

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
8	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 11/2016
4	CreatinineIBA 02/2024 - 10/2018
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023 - 01/2020
4	Vancomycin FDA LinkGeneric 01/2022 - 01/2019
3	C-Reactive ProteinIBA 01/2023 - 06/2017
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2021
3	AntibodiesIBA 01/2023 - 06/2013
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2016
3	SteroidsIBA 01/2022 - 11/2016
3	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2016
3	CytokinesIBA 11/2020 - 06/2013
3	ProcalcitoninIBA 02/2020 - 06/2017
2	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2022
2	ThrombomodulinIBA 02/2023 - 01/2023
2	Angiopoietin-1IBA 02/2023 - 01/2023
2	GlucocorticoidsIBA 01/2023 - 01/2021
2	Lipoproteins (Lipoprotein)IBA 01/2023 - 10/2020
2	VaccinesIBA 01/2023 - 02/2003
2	AntigensIBA 10/2022 - 12/2021
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018 - 10/2016
2	Ferritins (Ferritin)IBA 02/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 10/2016
1	humaninIBA 11/2023
1	Urea (Carbamide)FDA LinkGeneric 07/2023
1	NitrogenIBA 07/2023
1	CatecholaminesIBA 07/2023
1	LDL Receptors (LDL Receptor)IBA 02/2023
1	EndotoxinsIBA 02/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	ReninIBA 01/2023
1	Angiopoietin-2IBA 01/2023
1	AutoantibodiesIBA 01/2023
1	EndoglinIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 10/2021
1	tisagenlecleucelIBA 10/2021

Therapy/Procedure

37	Therapeutics 12/2023 - 03/2006
18	Critical Care (Surgical Intensive Care) 03/2024 - 02/2014
10	Artificial Respiration (Mechanical Ventilation) 01/2023 - 04/2016
8	Length of Stay 01/2023 - 11/2014
6	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2024 - 12/2017
5	Resuscitation 12/2023 - 09/2014
5	Extracorporeal Membrane Oxygenation 01/2023 - 12/2011
4	Cell Transplantation 11/2023 - 10/2018
4	Mechanical Ventilators (Ventilator) 01/2023 - 11/2014
3	Immunotherapy 07/2021 - 12/2020
2	Continuous Renal Replacement Therapy 01/2024 - 01/2023
2	Cardiopulmonary Resuscitation (CPR) 10/2022 - 01/2017
2	Induced Hypothermia 01/2021 - 10/2018
1	Organ Transplantation 03/2024
1	Fluid Therapy (Oral Rehydration Therapy) 12/2023
1	Noninvasive Ventilation 07/2023
1	Patient Readmission 07/2023
1	Tracheostomy 01/2023
1	Electric Countershock (Cardioversion) 10/2022